Established Investigator Awards
Established Investigator Awards support senior investigators with an established record of scientific productivity and accomplishment and who are past the initial four years of their first academic faculty appointment.
To learn more about MRA funded research awards, please visit CureMelanoma.org/Grants
Role of Opioid Signaling in Disabling Immunity During Melanoma Progression
MRA Established Investigator Award
Ana Anderson PhD, Brigham and Women’s Hospital
Formation and Function of Tertiary Lymphoid Structures in Melanoma
MRA Established Investigator Award
Victor Engelhard PhD, The University of Virginia
Targeting Neuroinflammation for Inhibition of Melanoma Brain Metastasis
MRA Established Investigator Award
Neta Erez PhD, Tel Aviv University
CSDE1 Proteoforms as Novel Targets for Melanoma Treatment and Prognosis
MRA Established Investigator Award
Fatima Gebauer PhD, Fundacio Centre De Regulacio Genomica
Targeted Therapy of Melanoma with LZTR1 and CRKL Inhibitors
MRA Established Investigator Award
Ruth Halaban PhD, Yale University
Identifying Defects in Nucleic Acid Sensing that Drive anti-PD-1 Resistance
MRA Established Investigator Award
Rizwan Haq MD, PhD, Dana-Farber Cancer Institute
Tailoring T cell Anti-Tumor Response with Mitochondria-Mediated Regulations
MRA Established Investigator Award
Ping-Chih Ho PhD, University of Lausanne
PARP14 Mediates Adaptive Resistance to Immune Checkpoint Inhibitors
MRA Established Investigator Award
Adam Hurlstone PhD, University of Manchester
Balancing Stem-Like and Effector T Cells for Maximal Anti-Tumor Activity
MRA Established Investigator Award, collaboratively funded by Massachusetts
General Hospital
Thorsten Mempel MD, PhD, Massachusetts General Hospital
Targeting Acral/Mucosal Melanomas Using a Novel KIT-driven Murine Avatar
Leveraged Finance Fights Melanoma-MRA Established Investigator Award
Hensin Tsao MD, PhD, Massachusetts General Hospital
Protein Kinase C Fusion — Rare Targetable Initiating Mutation in Melanoma
Leveraged Finance Fights Melanoma-MRA Established Investigator Award
Iwei Yeh MD, PhD, The University of California, San Francisco
Melanoma survivor and clinical trial participant Brandon Barniea and family.